tradingkey.logo

Pepgen Inc - U.S. FDA Places FREEDOM2 Trial On Partial Clinical Hold Related To Preclinical Pharmacology And Toxicology

ReutersMar 4, 2026 9:28 PM

- PepGen Inc PEPG.O:

  • PEPGEN INC: U.S. FDA PLACES FREEDOM2 TRIAL ON PARTIAL CLINICAL HOLD RELATED TO PRECLINICAL PHARMACOLOGY AND TOXICOLOGY

  • PEPGEN INC: REITERATES GUIDANCE FOR REPORTING DATA FROM FREEDOM2 5 MG/KG COHORT IN Q1 2026 AND FROM 10 MG/KG COHORT IN 2H 2026

  • PEPGEN INC - RECEIVES REGULATORY CLEARANCE TO INITIATE FREEDOM2 IN SOUTH KOREA, AUSTRALIA, AND NEW ZEALAND

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI